Merck Q2 Earnings Preview: Analysts Expect 11% Decline in EPS and 1.4% Revenue Decrease

Merck is set to report Q2 earnings on July 29th, with analysts expecting an 11% decline in EPS to $2.03 and a 1.4% decrease in revenue to $15.87B.

Merck & Co., Inc. (NYSE:MRK) is set to report its second-quarter earnings on Tuesday, July 29th, before the opening bell. Analysts expect an 11% decline in earnings per share (EPS) to $2.03, with a 1.4% decrease in revenue to $15.87 billion [3]. This comes as Merck navigates several challenges, including the failure of its Reblozyl anemia therapy in a Phase 3 trial for myelofibrosis and the start of late-stage clinical trials for its oral drug, MK-8527, aimed at preventing HIV [3].

Despite these setbacks, Merck has a history of beating expectations. Over the last eight quarters, the company has consistently surpassed EPS and revenue estimates, with a 88% success rate for EPS and 100% for revenue [3]. However, recent market trends suggest a 4.9% swing for Merck shares, with an average daily move of 4.2% on earnings days [2].

Investors are also watching Merck's dividend yield, currently at 3.82% annually, or 81 cents per share per quarter. To generate $500 monthly, an investor would need to own approximately 1,852 shares, valued at around $156,883 [1]. For a more conservative goal of $100 monthly, 370 shares, valued at $31,343, would be sufficient [1].

Merck's stock has seen a 15.3% year-to-date decline, compared to a 1.9% decline for the S&P 500 healthcare index and a 5.2% gain for the Dow Industrials [2]. The company's shares last traded at $84.25, below the median price target of $100, with 27 analyst ratings, including six 'strong buy,' ten 'buy,' and eleven 'hold' ratings [2].

References:

[1] How To Earn $500 A Month From Merck Stock Ahead Of Q2 Earnings. Benzinga. Retrieved from https://www.aol.com/earn-500-month-merck-stock-141223951.html

[2] Merck & Co MRK shares off ~0.6% on Mon ahead of Q2 financial report due before market open on Tues. Reuters. Retrieved from https://www.tradingview.com/news/reuters.com,2025:newsml_L6N3TP0SD:0-preview-merck-seen-reporting-q2-eps-drop-yr-yr-rev-increase/

[3] Merck Q2 Earnings Preview: What to Expect. Seeking Alpha. Retrieved from https://seekingalpha.com/news/4472805-merck-q2-earnings-preview-what-to-expect